Moomoo AI 已提取核心訊息
On January 23, 2024, 3M Company reported its financial results for the fourth quarter and full year of 2023, and provided its financial outlook for 2024. The company announced GAAP earnings per share of $1.70 for Q4 and an adjusted EPS of $2.42, reflecting an 11 percent increase year-on-year. The adjusted operating income margin expanded by 1.8 percentage points to 20.9%. For the full year, 3M reported a GAAP loss per share of $12.63, primarily due to significant litigation charges related to Combat Arms Earplugs and PFAS settlements. However, the adjusted EPS for the year stood at $9.24. The company's total sales for Q4 were $8.0 billion, a 0.8 percent decrease from the previous year, with an organic sales decline of 1.9 percent. Adjusted sales for the full year were $31.4 billion, down 4.5 percent year-on...Show More
On January 23, 2024, 3M Company reported its financial results for the fourth quarter and full year of 2023, and provided its financial outlook for 2024. The company announced GAAP earnings per share of $1.70 for Q4 and an adjusted EPS of $2.42, reflecting an 11 percent increase year-on-year. The adjusted operating income margin expanded by 1.8 percentage points to 20.9%. For the full year, 3M reported a GAAP loss per share of $12.63, primarily due to significant litigation charges related to Combat Arms Earplugs and PFAS settlements. However, the adjusted EPS for the year stood at $9.24. The company's total sales for Q4 were $8.0 billion, a 0.8 percent decrease from the previous year, with an organic sales decline of 1.9 percent. Adjusted sales for the full year were $31.4 billion, down 4.5 percent year-on-year. 3M also returned $828 million to shareholders through dividends in Q4 and $3.3 billion over the full year. The company's Health Care spin remains on track for the first half of 2024. For the upcoming year, 3M expects adjusted total sales growth in the range of 0.25 to 2.25 percent and an adjusted EPS in the range of $9.35 to $9.75. The company's chairman and CEO, Mike Roman, expressed confidence in delivering a successful 2024, highlighting the company's focus on operational performance, portfolio optimization, and investment in high-growth markets.
2024年1月23日，3M公司公佈了2023年第四季度和全年的財務業績，並提供了2024年的財務展望。該公司宣佈第四季度GAAP每股收益爲1.70美元，調整後的每股收益爲2.42美元，同比增長11％。調整後的營業收入利潤率增長了1.8個百分點至20.9％。3M公佈的全年每股GAAP虧損爲12.63美元，這主要是由於與作戰武器耳塞和全氟辛烷磺酸和解有關的重大訴訟費用。但是，調整後的年度每股收益爲9.24美元。該公司第四季度的總銷售額爲80億美元，比上年下降0.8％，有機銷售額下降1.9％。調整後的全年銷售額爲314億美元，同比下降4.5％。3M還通過第四季度分紅向股東返還了8.28億美元，全年回...展開全部
2024年1月23日，3M公司公佈了2023年第四季度和全年的財務業績，並提供了2024年的財務展望。該公司宣佈第四季度GAAP每股收益爲1.70美元，調整後的每股收益爲2.42美元，同比增長11％。調整後的營業收入利潤率增長了1.8個百分點至20.9％。3M公佈的全年每股GAAP虧損爲12.63美元，這主要是由於與作戰武器耳塞和全氟辛烷磺酸和解有關的重大訴訟費用。但是，調整後的年度每股收益爲9.24美元。該公司第四季度的總銷售額爲80億美元，比上年下降0.8％，有機銷售額下降1.9％。調整後的全年銷售額爲314億美元，同比下降4.5％。3M還通過第四季度分紅向股東返還了8.28億美元，全年回報了33億美元。該公司的醫療保健業務在2024年上半年仍步入正軌。3M預計，來年調整後的總銷售額增長在0.25％至2.25％之間，調整後的每股收益在9.35美元至9.75美元之間。該公司董事長兼首席執行官邁克·羅曼表示有信心在2024年取得成功，他強調了公司對運營業績、投資組合優化和對高增長市場的投資的關注。
有用
沒用